ID   MTRR_RAT                Reviewed;         700 AA.
AC   Q498R1; D3ZDG8;
DT   31-MAY-2011, integrated into UniProtKB/Swiss-Prot.
DT   31-MAY-2011, sequence version 2.
DT   29-MAY-2024, entry version 123.
DE   RecName: Full=Methionine synthase reductase;
DE            Short=MSR;
DE            EC=1.16.1.8 {ECO:0000250|UniProtKB:Q9UBK8};
DE   AltName: Full=Aquacobalamin reductase;
DE            Short=AqCbl reductase;
GN   Name=Mtrr;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Thymus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Key enzyme in methionine and folate homeostasis responsible
CC       for the reactivation of methionine synthase (MTR/MS) activity by
CC       catalyzing the reductive methylation of MTR-bound cob(II)alamin.
CC       Cobalamin (vitamin B12) forms a complex with MTR to serve as an
CC       intermediary in methyl transfer reactions that cycles between MTR-bound
CC       methylcob(III)alamin and MTR bound-cob(I)alamin forms, and occasional
CC       oxidative escape of the cob(I)alamin intermediate during the catalytic
CC       cycle leads to the inactive cob(II)alamin species. The processing of
CC       cobalamin in the cytosol occurs in a multiprotein complex composed of
CC       at least MMACHC, MMADHC, MTRR and MTR which may contribute to shuttle
CC       safely and efficiently cobalamin towards MTR in order to produce
CC       methionine (By similarity). Also necessary for the utilization of
CC       methyl groups from the folate cycle, thereby affecting
CC       transgenerational epigenetic inheritance (By similarity). Also acts as
CC       a molecular chaperone for methionine synthase by stabilizing apoMTR and
CC       incorporating methylcob(III)alamin into apoMTR to form the holoenzyme.
CC       Also serves as an aquacob(III)alamin reductase by reducing
CC       aquacob(III)alamin to cob(II)alamin; this reduction leads to
CC       stimulation of the conversion of apoMTR and aquacob(III)alamin to MTR
CC       holoenzyme (By similarity). {ECO:0000250|UniProtKB:Q8C1A3,
CC       ECO:0000250|UniProtKB:Q9UBK8}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + 2 methylcob(III)alamin-[methionine synthase] + NADP(+)
CC         + 2 S-adenosyl-L-homocysteine = 2 cob(II)alamin-[methionine synthase]
CC         + NADPH + 2 S-adenosyl-L-methionine; Xref=Rhea:RHEA:23908, Rhea:RHEA-
CC         COMP:14714, Rhea:RHEA-COMP:14715, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16304, ChEBI:CHEBI:28115, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:57856, ChEBI:CHEBI:58349, ChEBI:CHEBI:59789; EC=1.16.1.8;
CC         Evidence={ECO:0000250|UniProtKB:Q9UBK8};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:23910;
CC         Evidence={ECO:0000250|UniProtKB:Q9UBK8};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=A + 2 cob(II)alamin + 2 H(+) + 2 H2O = AH2 + 2
CC         aquacob(III)alamin; Xref=Rhea:RHEA:20752, ChEBI:CHEBI:13193,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15852,
CC         ChEBI:CHEBI:16304, ChEBI:CHEBI:17499;
CC         Evidence={ECO:0000250|UniProtKB:Q9UBK8};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:20754;
CC         Evidence={ECO:0000250|UniProtKB:Q9UBK8};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000250|UniProtKB:Q9UBK8};
CC   -!- COFACTOR:
CC       Name=FMN; Xref=ChEBI:CHEBI:58210;
CC         Evidence={ECO:0000250|UniProtKB:Q9UBK8};
CC   -!- SUBUNIT: Forms a multiprotein complex with MMACHC, MMADHC and MTR.
CC       {ECO:0000250|UniProtKB:Q9UBK8}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9UBK8}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q498R1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q498R1-2; Sequence=VSP_041294;
CC   -!- MISCELLANEOUS: It is debated whether the reduction of free
CC       aquacob(II)alamin occurs spontaneously or is enzyme catalyzed.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH474002; EDL87600.1; -; Genomic_DNA.
DR   EMBL; BC100107; AAI00108.1; -; mRNA.
DR   RefSeq; NP_001034092.1; NM_001039003.1. [Q498R1-2]
DR   RefSeq; XP_006227875.1; XM_006227813.3. [Q498R1-1]
DR   AlphaFoldDB; Q498R1; -.
DR   SMR; Q498R1; -.
DR   STRING; 10116.ENSRNOP00000024041; -.
DR   PhosphoSitePlus; Q498R1; -.
DR   PaxDb; 10116-ENSRNOP00000024041; -.
DR   Ensembl; ENSRNOT00000061790.4; ENSRNOP00000058505.2; ENSRNOG00000017826.7. [Q498R1-2]
DR   Ensembl; ENSRNOT00000094903.1; ENSRNOP00000078665.1; ENSRNOG00000017826.7. [Q498R1-1]
DR   Ensembl; ENSRNOT00055036349; ENSRNOP00055029541; ENSRNOG00055021272. [Q498R1-1]
DR   Ensembl; ENSRNOT00060000768; ENSRNOP00060000157; ENSRNOG00060000685. [Q498R1-1]
DR   Ensembl; ENSRNOT00065003414; ENSRNOP00065002349; ENSRNOG00065002580. [Q498R1-1]
DR   GeneID; 290947; -.
DR   KEGG; rno:290947; -.
DR   UCSC; RGD:1308671; rat. [Q498R1-1]
DR   AGR; RGD:1308671; -.
DR   CTD; 4552; -.
DR   RGD; 1308671; Mtrr.
DR   eggNOG; KOG1158; Eukaryota.
DR   GeneTree; ENSGT00940000155822; -.
DR   HOGENOM; CLU_001570_17_0_1; -.
DR   InParanoid; Q498R1; -.
DR   OMA; LFFGHQR; -.
DR   OrthoDB; 276396at2759; -.
DR   TreeFam; TF105716; -.
DR   Reactome; R-RNO-156581; Methylation.
DR   Reactome; R-RNO-1614635; Sulfur amino acid metabolism.
DR   Reactome; R-RNO-9759218; Cobalamin (Cbl) metabolism.
DR   PRO; PR:Q498R1; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Proteomes; UP000234681; Chromosome 1.
DR   Bgee; ENSRNOG00000017826; Expressed in quadriceps femoris and 19 other cell types or tissues.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0045111; C:intermediate filament cytoskeleton; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0030586; F:[methionine synthase] reductase activity; ISO:RGD.
DR   GO; GO:0071949; F:FAD binding; ISO:RGD.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; ISS:UniProtKB.
DR   GO; GO:0010181; F:FMN binding; ISO:RGD.
DR   GO; GO:0070402; F:NADPH binding; ISO:RGD.
DR   GO; GO:0003958; F:NADPH-hemoprotein reductase activity; ISO:RGD.
DR   GO; GO:0016723; F:oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor; ISS:UniProtKB.
DR   GO; GO:0009235; P:cobalamin metabolic process; ISO:RGD.
DR   GO; GO:0046655; P:folic acid metabolic process; ISS:UniProtKB.
DR   GO; GO:0043418; P:homocysteine catabolic process; ISO:RGD.
DR   GO; GO:0050667; P:homocysteine metabolic process; ISO:RGD.
DR   GO; GO:0009086; P:methionine biosynthetic process; ISO:RGD.
DR   GO; GO:0033353; P:S-adenosylmethionine cycle; ISO:RGD.
DR   CDD; cd06203; methionine_synthase_red; 1.
DR   Gene3D; 3.40.50.360; -; 1.
DR   Gene3D; 3.40.50.80; Nucleotide-binding domain of ferredoxin-NADP reductase (FNR) module; 1.
DR   Gene3D; 2.40.30.10; Translation factors; 1.
DR   InterPro; IPR003097; CysJ-like_FAD-binding.
DR   InterPro; IPR017927; FAD-bd_FR_type.
DR   InterPro; IPR001094; Flavdoxin-like.
DR   InterPro; IPR008254; Flavodoxin/NO_synth.
DR   InterPro; IPR001709; Flavoprot_Pyr_Nucl_cyt_Rdtase.
DR   InterPro; IPR029039; Flavoprotein-like_sf.
DR   InterPro; IPR039261; FNR_nucleotide-bd.
DR   InterPro; IPR023173; NADPH_Cyt_P450_Rdtase_alpha.
DR   InterPro; IPR001433; OxRdtase_FAD/NAD-bd.
DR   InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR   PANTHER; PTHR19384:SF84; METHIONINE SYNTHASE REDUCTASE; 1.
DR   PANTHER; PTHR19384; NITRIC OXIDE SYNTHASE-RELATED; 1.
DR   Pfam; PF00667; FAD_binding_1; 1.
DR   Pfam; PF00258; Flavodoxin_1; 1.
DR   Pfam; PF00175; NAD_binding_1; 1.
DR   PRINTS; PR00369; FLAVODOXIN.
DR   PRINTS; PR00371; FPNCR.
DR   SUPFAM; SSF52343; Ferredoxin reductase-like, C-terminal NADP-linked domain; 1.
DR   SUPFAM; SSF52218; Flavoproteins; 1.
DR   SUPFAM; SSF63380; Riboflavin synthase domain-like; 1.
DR   PROSITE; PS51384; FAD_FR; 1.
DR   PROSITE; PS50902; FLAVODOXIN_LIKE; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Amino-acid biosynthesis; Cytoplasm; FAD;
KW   Flavoprotein; FMN; Methionine biosynthesis; NADP; Oxidoreductase;
KW   Phosphoprotein; Reference proteome; S-adenosyl-L-methionine.
FT   CHAIN           1..700
FT                   /note="Methionine synthase reductase"
FT                   /id="PRO_0000409309"
FT   DOMAIN          4..147
FT                   /note="Flavodoxin-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00088"
FT   DOMAIN          272..534
FT                   /note="FAD-binding FR-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00716"
FT   REGION          168..247
FT                   /note="Hinge"
FT                   /evidence="ECO:0000250"
FT   BINDING         10..14
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00088"
FT   BINDING         93..124
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00088"
FT   BINDING         292
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250"
FT   BINDING         452..455
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250"
FT   BINDING         488..491
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250"
FT   BINDING         611..612
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250"
FT   BINDING         626..628
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250"
FT   BINDING         661
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250"
FT   BINDING         699
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         173
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UBK8"
FT   MOD_RES         190
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UBK8"
FT   VAR_SEQ         44..237
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_041294"
SQ   SEQUENCE   700 AA;  78025 MW;  13EAE5AE46606F11 CRC64;
     MRRFLLLYAT QRGQAKAIAE EISEQALSHG FSADLHCVSE SEKYDLKTET GPLVMVVSTT
     GTGDPPDTAR KFVKEIHNKT LPTDFFAHLW YGLLGLGDSE YTYFCNGGKV IDKRLQELGA
     QHFYDTGHAD DCVGLELVVE PWIDGLWPAL TKHFKSLGGQ EDMSDSDTLA QASDAPLSMA
     MKPELLHIQS QVELLSLEDV GKRDSELQEQ NETNKNQPSR IEDFDSSLVN SVPPLSQSSL
     SIPAVSPEYL EVYLQESLGQ DENQASVPPS VDPIFQVPIS KAVELTTNDA IKTTLLLELD
     ISKVEFSHQP GDSFNVICPN SGSEVEDLLQ RLQLADKQAH RVILKIKMDT KKKGASLPQH
     VPEGSSLQFI FTWCLEIRAV PKKAFLRALS DYTSDATEKR RLQELCSKQG AADYNRFIRD
     ASVCLLDLLL TFPSCQPPLN LLLEHLPKLQ PRPYSCASSS LLHPDKLHFV FNIVELPSNT
     TAASLRKGVC TGWLATLVAP FLQPNTEVLT ADHSDALAPE ILISPRATNS FHLPDDLSAP
     IIMVGPGTGV APFVGFLQHR EKLQEQHPDG NFGAMWLFFG CRHKDRDYLF REELRHFLKT
     GVLTHLKVSF SRDAAPEEEE EAPAKYVQDN LQHHSQQVAR TLLQENGYIY VCGDAKNMAK
     DVHDALVEII SKEAGVDKLE AMKTLATLKQ EKRYLQDIWS
//
